
January 12, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Celgene, Mark Alles

January 12, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Drug pricing, Duchenne Muscular Dystrophy, Translarne, access to medicines, ataluren, muscular dystrophy, rare disease, ultra orphan drugs, ultra-orphan drugs

January 12, 2016 Manufacturing and Production, Research and Development Roche, Tensha Therapeutics

January 11, 2016 Research and Development AbbVie, clinical trials, hepatitis C, phase III

January 11, 2016 Manufacturing and Production, Research and Development, Sales and Marketing ABT-494, AbbVie, F-star, JAK-1 inhibitor, rheumatoid arthritis

January 11, 2016 Research and Development, Sales and Marketing Sanofi, Warp Drive Bio, antibodies, collaboration, immuno-oncology, research

January 11, 2016 Research and Development, Sales and Marketing Cancer, Novartis, Surface Oncology, collaboration, immuno-oncology

January 8, 2016 Medical Communications, Research and Development Roche, atezolizumab, bladder cancer

January 7, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Molplex, Victoria Camargo

January 7, 2016 Manufacturing and Production, Medical Communications, Research and Development Edurant, HIV, Janssen, ViiV Healthcare, cabotegravir, collaboration, phase III, rilpivirine

January 7, 2016 Manufacturing and Production, Medical Communications, Research and Development Cancer, Dr Paolo Paoletti, GSK, PsiOxus Therapeutics, immuno-oncology, oncology

January 7, 2016 Research and Development BRAF mutations, Diagnostics, Erbitux, Merck, RAS metations, diagnostic tests, metastic colorectal cancer

January 7, 2016 Research and Development Crohn's, Crohn’s disease, Enterome, Janssen, MD Anderson, alliance, antibodies, collaboration, crohn's disease, immuno-oncology, kymab, research

January 6, 2016 Research and Development Gilead, IPF, idiopathic pulmonary fibrosis, simtuzumab

January 6, 2016 Research and Development Cancer Research UK, active surveillance, exercise, prostate cancer